Connect with us

Business

Banks hold FTSE 100 back on windfall tax worry

Published

on

Banks hold FTSE 100 back on windfall tax worry



The FTSE 100 ended Friday on the back foot as banking stocks came under pressure amid reports that the UK Government is considering a windfall tax on the sector.

The FTSE 100 index closed down 29.48 points, 0.3%, at 9,187.34.

The FTSE 250 ended 138.68 points lower, 0.6%, at 21,605.72 but the AIM All-Share finished up 2.89 points, 0.4%, at 764.10.

For the week, the FTSE 100 shed 1.3%, the FTSE 250 fell 1.0% and the AIM All-Share rose 0.4%.

Banking stocks in London were rocked by reports that Chancellor Rachel Reeves could target the sector to help shore up public finances.

Lenders NatWest, Lloyds Banking Group and Barclays PLC fell 4.9%, 3.4% and 2.2% respectively in London.

On Friday, a report by the Institute for Public Policy Research said the Treasury should impose a new levy to recoup “windfalls” made by lenders as a legacy of the Bank of England’s quantitative easing programme, undertaken in the wake of the financial crisis.

The think-tank said the UK taxpayer is spending £22 billion a year compensating the BoE for losses on the programme.

The scheme entailed the BoE purchasing hundreds of billions of pounds of government bonds, buoying commercial bank reserves at the central bank.

These are now being remunerated at the BoE’s official rate, which stands at 4.0%.

The IPPR recommended that the Treasury introduce a QE reserves income levy on commercial banks to save £7 billion to £8 billion a year over this parliament.

In addition, it suggests the BoE slows down quantitative tightening, by ending its fire sale of government bonds, to save more than £12 billion a year.

The Financial Times on Friday said fears are mounting that the autumn budget will target banks to help fill a £20 billion fiscal hole.

“Politically it is an easy target,” a senior banker told the FT. “No-one likes banks, they are seen as a whipping boy for the Government.”

Kathleen Brooks, research director at XTB, said August has seen a “torrent of leaks” from government and the Treasury about potential tax rises, ahead of the autumn budget.

“Tax rises that have been proposed include increases in capital gains tax, property tax rises, national insurance hikes on rental income and a levy on banks, among others.

“The impact of this drip feed of potential tax rises is eroding confidence and dimming the prospects for the UK economy. It is also starting to impact UK asset prices,” she said.

Faring better, ConvaTec, which rose 1.4% as interim chief executive Jonny Mason and interim chief financial officer Fiona Ryder picked up £167,000 of shares between them.

They took their interim roles after chief executive Karim Bitar went on a medical leave of absence earlier this month.

Prudential rose 2.3% as Bank of America said the insurer was its top sector pick, highlighting forecast dividend growth and share buybacks.

In New York at the time of the London equities close, the Dow Jones Industrial Average was down 0.4%, the S&P 500 was 0.7% lower, while the Nasdaq Composite was down 1.0%.

Across the pond, traders weighed a pick-up in inflation, albeit in line with expectations.

The Bureau of Economic Analysis said the headline personal consumption expenditures price index rose 0.2% month-on-month in July, slowing from 0.3% growth in June, and by 2.6% year-on-year, the rate unchanged from June.

Excluding food and energy, core PCE price index increased 0.3% on-month, the same pace of growth as in June, and by 2.9% on-year, accelerating from 2.8% in the 12 months to June.

The figures were in line with FXStreet-cited market consensus.

Core PCE is the Federal Reserve’s preferred inflationary gauge, and Friday’s reading will play an important part in how the FOMC acts at its September meeting.

The yield on the US 10-year Treasury was at 4.22%, flat from Thursday. The yield on the US 30-year Treasury was 4.93%, stretched from 4.89%.

The pound eased to 1.3510 US dollars late on Friday in London, compared to 1.3513 US dollars at the equities close on Thursday.

The euro rose to 1.1699 US dollars, against 1.1668 US dollars. Against the yen, the dollar was trading lower at 146.92 yen, compared to 147.02 yen.

In Europe, the CAC 40 in Paris ended down 0.7%, while the DAX 40 in Frankfurt closed 0.6% lower.

In London, takeover activity kept traders busy.

John Wood finally agreed a bid of about £210 million from long-term suitor Dar Al-Handasah Consultants Shair and Partners Holdings, known as Sidara, worth 30 pence for each Wood share.

In addition, Sidara said it will provide a 450 million US dollar capital injection into John Wood to provide financial stability, although the long-running takeover saga remains subject to several conditions.

John Wood chief executive Ken Gilmartin said the deal brings “us closer to finalising a challenging chapter in Wood’s history”.

“The acquisition by Sidara will solve our near-term liquidity challenges and strengthen the company in the longer term,” he added.

The agreement is subject to a number of conditions including publication of 2024 audited accounts on or before the end of October and the audit opinion not being the subject of any modified opinion in relation to the 2024 balance sheet.

Shares in Wood are currently suspended at 18.20p pending publication of 2024 accounts.

Meanwhile, JTC shot up 18% for a market value of £1.92 billion as it said its board has rejected a takeover proposal from private equity firm Permira Advisers.

Earlier on Friday, Permira said it approached the Jersey-based professional services company regarding a possible cash offer for the business.

Permira and JTC did not detail the terms of any potential offer.

However, Bloomberg reported, citing people with knowledge of the matter, that Permira has made a proposal to purchase JTC that values it at about £2 billion.

“We think there is quite a good chance of a bid – this is a market that PE has been active in and that Permira knows well,” analysts at RBC Capital Markets said.

A barrel of Brent traded at 67.41 US dollars late Friday, down from 67.51 US dollars on Thursday. Gold climbed to 3,445.38 US dollars an ounce against 3,407.04 US dollars on Thursday.

The biggest risers on the FTSE 100 were Rentokil Initial, up 9.0p at 365.0p, Prudential, up 22.2 pence at 988.6p, Fresnillo, up 35.0p at 1,788.0p, Endeavour Mining, up 44.0p at 2,536.0p, and ConvaTec, up 3.2p at 236.5p.

The biggest fallers on the FTSE 100 were NatWest, down 26.0p at 510.6p, JD Sports Fashion, down 4.0p at 96.0p, Lloyds Banking Group, down 2.7p at 79.5p, Barclays, down 8.2p at 360.4p and Kingfisher, down 5.9p at 257.4p.

Monday’s local corporate calendar has a trading statement from Workday partner and provider of IT services, Kainos Group, and half-year results from leisure and entertainment company, XP Factory.

The global economic calendar on Monday has a slew of manufacturing PMI releases, eurozone unemployment figures, and UK mortgage approvals data. US financial markets are closed for Labour Day.

Contributed by Alliance News



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Anthropic officially designated a supply chain risk by Pentagon

Published

on

Anthropic officially designated a supply chain risk by Pentagon



The supply chain risk designation of the artificial intelligence firm is a first for a US company.



Source link

Continue Reading

Business

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease

Published

on

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease


Thomas Fuller | SOPA Images | Lightrocket | Getty Images

UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday.

The official, who requested anonymity before discussing sensitive information, confirmed the agency has asked the company to run a placebo controlled trial of its treatment, which is administered directly into the brain. UniQure has said that type of study isn’t ethical because it would require putting people under general anesthesia for hours, a characterization the official disputed.

“So what is really going on? UniQure is the latest company to make a failed therapy for Huntington’s patients,” the official said. “They likely acknowledge or understand at some deep level that their trial failed years ago, and instead of doing the right thing and running the correct clinical study, UniQure is performing a distorted or manipulated comparison in the mind of FDA.”

The comments mark the latest development in a messy public spat between UniQure and the FDA, and as the agency comes under fire for a number of recent drug approval application rejections, including some where companies have accused it of going back on previous guidance. FDA Commissioner Marty Makary in an interview with CNBC’s Becky Quick last week seemingly criticized UniQure’s gene therapy for Huntington’s disease. Makary didn’t name UniQure but described its treatment.

UniQure then accused the FDA of reversing its stance that the company’s clinical trial data would be sufficient to seek approval. UniQure’s study used an outside database to measure how patients with Huntington’s disease might decline without treatment, known as an external control. UniQure has said it wouldn’t be feasible to run a true randomized, double-blind placebo-controlled study, considered the gold standard, because it wouldn’t be ethical to make people undergo a sham hours-long brain surgery.

The FDA official said the agency “never agreed to accept this distorted comparison” and the FDA “never makes such assurances.” Instead, the “FDA will always say, ‘Well, we have to see the data when we get it.'”

UniQure didn’t immediately comment.

The company’s stock rose more than 10% on Thursday and has fallen 58% this year as of Thursday afternoon.



Source link

Continue Reading

Business

Ogra warns of strict action against illegal hoarding of petroleum products – SUCH TV

Published

on

Ogra warns of strict action against illegal hoarding of petroleum products – SUCH TV



The Oil and Gas Regulatory Authority (Ogra) on Thursday warned of strict action against any individual or entity found involved in the illegal hoarding of petroleum products at unauthorised locations, particularly at places other than duly licensed oil depots and retail outlets of Oil Marketing Companies (OMCs).

In a statement, an Ogra spokesperson said: “Any premises found involved in the illegal storage of petroleum products will be sealed.”

The spokesperson assured the public that the country currently holds sufficient stocks of petroleum products to meet national demand and that there is no need for panic buying or hoarding.

In view of the prevailing geopolitical situation, the official said that the authorities are closely monitoring the petroleum supply chain to ensure the uninterrupted availability of products across the country.

“The existing stock position remains comfortable and well within the prescribed requirements,” read the statement.

Reports have indicated that certain elements may attempt to hoard petroleum products for profiteering under such circumstances, the spokesperson said, adding: “To curb such practices, all provincial chief secretaries have been requested to direct deputy commissioners (DCs) to conduct inspections within their respective jurisdictions.”

Meanwhile, teams of Ogra are actively monitoring the situation in the field, the official added.

Inspections are being carried out at oil depots and retail outlets to ensure the smooth supply of petroleum products and to prevent any malpractice, read the statement.

Ogra advised the public not to pay attention to rumours and to maintain normal consumption patterns, as the petroleum supply situation in the country remains stable.

Uninterrupted petroleum supply top priority: FinMin

Separately, Finance Minister Muhammad Aurangzeb has said that ensuring uninterrupted availability of petroleum products across the country is the government’s top priority.

The finance czar made the remarks while chairing a meeting of the committee to Monitor Petrol Prices in the Wake of the Emerging Situation in the region, constituted by Prime Minister Shehbaz Sharif, in Islamabad today.

The committee was briefed that national reserves remain at comfortable levels, with sufficient cover available for key products, and that there is no immediate cause for concern regarding the availability of petroleum products.

It reviewed multiple supply and pricing scenarios to ensure preparedness under different contingencies and to maintain stability in domestic energy supplies.

The committee will finalise its recommendations by tomorrow for onward submission to the prime minister.

It will continue to meet on a daily basis to monitor developments, review stock positions and supply chain movements, and ensure timely execution across all stakeholders.

The committee also noted that “war premium” dynamics and intensified competition for energy cargoes, particularly in Asian markets, could raise external account pressures if volatility persists.

The body reviewed ongoing efforts to strengthen supply assurance through diversified sourcing and logistics arrangements.

The committee also considered shipping and operational measures to reduce time lags, including facilitation of timely berthing and the use of available national shipping capacity where feasible.

To safeguard orderly market conditions, the committee discussed measures to deter hoarding, illegal storage, and diversion, including coordinated enforcement actions by provincial administrations in close collaboration with the Ogra and relevant agencies.

The committee emphasised that preventing outward smuggling and ensuring uninterrupted domestic distribution will remain a top operational priority, and that real-time field intelligence and strict action against violations will be maintained.



Source link

Continue Reading

Trending